804 patents currently held
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Apr 2039. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Apr 2039
Next term end
651
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Jun 2043 · High confidence
Also notable
Ends Feb 2043 · High confidence
Also notable
Ends Mar 2043 · High confidence
Charge Transportation in Nanostructured Functional Selenium-Containing Liquid Crystalline Materials
US 11,814,346
The most cited patent in this portfolio, cited by 6 later US patents, top 25% of utility patents granted in 2023 in our data. Protection runs to 2043.
Benzofuro[3,2-c]chromen-6-one Compounds as Antibacterial Agents
US 11,802,130
The newest of the three, granted 2023. It anchors the portfolio to 2043, later than anything else here.
COVID-19 Binding Aerosols
US 11,813,287
The newest of the three, granted 2023. It anchors the portfolio to 2043, later than anything else here.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Nov 23, 2026The maintenance fee for Therapeutic Agents for Treating and Preventing Autoimmune Diseases and Cancer and a Screening Method (US 11,654,138) comes due Nov 23, 2026. Unpaid by May 24, 2027, it lapses early.
- 1 fee due Dec 20, 2026The maintenance fee for Double "J" Laparoscopic Fascial Closure Device (US 11,678,874) comes due Dec 20, 2026. Unpaid by Jun 21, 2027, it lapses early.
- 1 fee due Jan 25, 2027The maintenance fee for Fusion Peptide Inhibitors of Human Coronavirus 229E (US 11,707,504) comes due Jan 25, 2027. Unpaid by Jul 26, 2027, it lapses early.
- 8 fees due Feb 15 to 28, 2027 · next Feb 15
- 8 fees due Mar 19 to 26, 2027 · next Mar 19
- 23 fees due Apr 3 to 30, 2027 · next Apr 3
- 37 fees due May 7 to 28, 2027 · next May 7
- 24 fees due Jun 5 to 26, 2027 · next Jun 5
- 46 fees due Jul 2 to 30, 2027 · next Jul 2
- 68 fees due Aug 6 to 27, 2027 · next Aug 6
- 85 fees due Sep 5 to 26, 2027 · next Sep 5
- 114 fees due Oct 2 to 30, 2027 · next Oct 2
- 51 fees due Nov 7 to 14, 2027 · next Nov 7
Recent changes
- 2 of the patents on this record were granted since Aug 20, 2026
- 2 terms have ended since Aug 20, 2026
What they patent
The 5 largest of its 651 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,654,138 | Therapeutic Agents for Treating and Preventing Autoimmune Diseases and Cancer and a Screening Method In force · High confidence | In force | High confidence | |
| US 11,773,137 | Novel ARID5A Peptide Inhibitors In force · High confidence | In force | High confidence | |
| US D1,090,833 | Single "J" Laparoscopic Fascial Closure Device In force · High confidence | In force | High confidence | |
| US 11,472,715 | Method of Making Carbon-Zinc Oxide Nanoparticles In force · High confidence | In force | High confidence | |
| US D1,120,322 | Clip for Laparoscopic Surgical Procedures In force · High confidence | In force | High confidence | |
| US 11,981,641 | 4,5-BIS(4-Bromophenyl)-1-Hexyl-2-(3,4-Dimethoxyphenyl)-1H-IMIDAZOLE as an Antimicrobial Compound In force · High confidence | In force | High confidence | |
| US 11,479,582 | ANTI-SARS-COV-2 Fusion Peptides In force · High confidence | In force | High confidence | |
| US 11,602,519 | Method for Preventing Myocardial Infarction Using Eucalyptol In force · High confidence | In force | High confidence | |
| US 11,478,464 | Method for Treating Inflammation In force · High confidence | In force | High confidence | |
| US 11,898,235 | Method of Making Metal Nanostructures Using Low Temperature Deposition In force · High confidence | In force | High confidence |
Also on record, not counted in the 804: 1 patent in force now held by others · 14 patents ended · 5 applications pending · 164 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.